NBK Capital exits Dem Pharmaceutical

NBK Capital Partners said Sunday it has realized its mezzanine investment in Dem Pharmaceutical. Istanbul, Turkey-based Dem Pharma is an importer and exporter of niche pharmaceutical products including blood products, hospital antibiotics, and hematology/oncology drugs that are used to treat life-threatening conditions.

DealsNorth AmericaUSBriefs